Northern Trust’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-26,943
| Closed | -$34K | – | 4348 |
|
|
2017
Q4 | $34K | Buy |
26,943
+570
| +2% | +$719 | ﹤0.01% | 4112 |
|
|
2017
Q3 | $56K | Buy |
26,373
+106
| +0.4% | +$225 | ﹤0.01% | 4049 |
|
|
2017
Q2 | $76K | Sell |
26,267
-122
| -0.5% | -$353 | ﹤0.01% | 4029 |
|
|
2017
Q1 | $90K | Sell |
26,389
-148
| -0.6% | -$505 | ﹤0.01% | 3978 |
|
|
2016
Q4 | $46K | Buy |
26,537
+6,410
| +32% | +$11.1K | ﹤0.01% | 4019 |
|
|
2016
Q3 | $66K | Sell |
20,127
-1,196
| -6% | -$3.92K | ﹤0.01% | 3968 |
|
|
2016
Q2 | $91K | Sell |
21,323
-102,421
| -83% | -$437K | ﹤0.01% | 3916 |
|
|
2016
Q1 | $696K | Sell |
123,744
-308
| -0.2% | -$1.73K | ﹤0.01% | 3366 |
|
|
2015
Q4 | $2.13M | Buy |
124,052
+2,789
| +2% | +$48K | ﹤0.01% | 3030 |
|
|
2015
Q3 | $2.56M | Sell |
121,263
-14,299
| -11% | -$302K | ﹤0.01% | 2892 |
|
|
2015
Q2 | $6.71M | Sell |
135,562
-2,261
| -2% | -$112K | ﹤0.01% | 2326 |
|
|
2015
Q1 | $10.8M | Buy |
137,823
+700
| +0.5% | +$54.8K | ﹤0.01% | 2030 |
|
|
2014
Q4 | $8.31M | Sell |
137,123
-2,906
| -2% | -$176K | ﹤0.01% | 2157 |
|
|
2014
Q3 | $5.97M | Buy |
140,029
+1,921
| +1% | +$81.8K | ﹤0.01% | 2401 |
|
|
2014
Q2 | $8.54M | Sell |
138,108
-693
| -0.5% | -$42.8K | ﹤0.01% | 2145 |
|
|
2014
Q1 | $9.02M | Sell |
138,801
-12,239
| -8% | -$796K | ﹤0.01% | 2184 |
|
|
2013
Q4 | $8.5M | Buy |
151,040
+14,138
| +10% | +$796K | ﹤0.01% | 2192 |
|
|
2013
Q3 | $8.39M | Buy |
136,902
+7,347
| +6% | +$450K | ﹤0.01% | 2146 |
|
|
2013
Q2 | $7.57M | Buy |
+129,555
| New | +$7.57M | ﹤0.01% | 2129 |
|